A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

Journal article (2020)

Authors

Sven J. van der Lee Vrije Universiteit Amsterdam
E.B. van den Akker Leiden University Medical Center, Molecular Epidemiology, Pattern Recognition and Bioinformatics - EEMCS
Najada Stringa Amsterdam UMC
M. Hulsman Pattern Recognition and Bioinformatics - EEMCS , Vrije Universiteit Amsterdam
N. Tesi Pattern Recognition and Bioinformatics - EEMCS , Vrije Universiteit Amsterdam
M.J.T. Reinders Pattern Recognition and Bioinformatics - EEMCS , Delft Bioinformatics Lab
More Authors More Authors External organisation
Research Group
Pattern Recognition and Bioinformatics (EEMCS) (TU Delft)
More Info
expand_more

Published Date

2020

Language

English

Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Faculty

Electrical Engineering, Mathematics and Computer Science

Department

Intelligent Systems

Research Group

Pattern Recognition and Bioinformatics

Abstract

The IPDGC (The International Parkinson Disease Genomics Consortium) and EADB (Alzheimer Disease European DNA biobank) are listed correctly as an author to the article, however, they were incorrectly listed more than once.